Extend Biosciences

company

About

Extend Biosciences is an emerging biotechnology company developing a novel drug delivery platform technology.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$150K
Industries
Biotechnology
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

Extend Biosciences Inc. is an emerging biotechnology company developing a novel drug delivery platform technology that improves the pharmacokinetic properties of peptides and proteins. Peptides have been particularly challenging to bring to market because they are removed from circulation prior to administering therapeutic value. Their proprietary platform technology significantly improves the circulating half-life and bioavailability of peptides and proteins, enabling the scientific community to truly develop potent and specific drugs. Their mission is to revolutionize drug delivery and give patients a better quality of life.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.05M
Extend Biosciences has raised a total of $1.05M in funding over 2 rounds. Their latest funding was raised on Nov 10, 2014 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 10, 2014 Grant $0.90M 1 National Science Foundation Detail
Dec 18, 2012 Grant $150K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Extend Biosciences is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant